Target Identification
Target Identification
Discover novel drug targets using curated SCREEN-WELL compound libraries, biochemical assays, and cell-based screening tools for early-stage discovery.
Finding the Right Targets for Drug Discovery
Target identification is the critical first step in the drug discovery pipeline — finding the molecular targets whose modulation can alter disease progression. Enzo Life Sciences provides a comprehensive toolkit for target discovery, including curated SCREEN-WELL compound libraries for phenotypic screening, biochemical assays for target deconvolution, and cell-based platforms for functional target identification. Our tools have powered target discovery programs across oncology, immunology, neurodegeneration, and infectious disease.
SCREEN-WELL Compound Libraries
Curated collections of bioactive compounds, natural products, and FDA-approved drugs for phenotypic and target-based screening. Pre-plated in microplate formats with detailed mechanism-of-action annotations to accelerate target deconvolution from hit lists.
Biochemical Target Assays
Enzymatic activity assays covering kinases, proteases, phosphatases, HDACs, and sirtuins for target identification and prioritization. Our validated kits enable rapid biochemical profiling of potential targets with excellent Z’-factor performance.
Cell-Based Screening
Functional cell-based assays for phenotypic target discovery including apoptosis, autophagy, proliferation, and reporter gene platforms. CYTO-ID and APOPCYTO detection kits enable multiparameter phenotypic profiling in automated workflows.
Pathway Profiling Tools
Signal transduction pathway reagents and modulators for mapping target-pathway relationships. Interrogate NF-κB, MAPK, PI3K/Akt, and Wnt signaling with validated tool compounds and downstream readout assays.
Target Identification — By the Numbers
Start Your Target Discovery Program
Explore our curated product selection or contact our scientific support team for personalized recommendations.